Claraphi Advisory Network’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Claraphi Advisory Network’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-300	Closed	-$23K	–	1201
2020 Q1	$23K	Buy	+300	New	+$26.6K	0.01%	608
2019 Q4	–	Sell	-522	Closed	-$40K	–	403
2019 Q3	$40K	Buy	+522	New	+$43.4K	0.02%	282
2019 Q1	–	Sell	-3,099	Closed	-$222K	–	256
2018 Q4	$222K	Sell	3,099 -357	-10%	-$28.8K	0.17%	168
2018 Q3	$331K	Buy	3,456 +1,096	+46%	+$106K	0.18%	147
2018 Q2	$225K	Sell	2,360 -6,014	-72%	-$553K	0.15%	218
2018 Q1	$735K	Buy	8,374 +3,393	+68%	+$310K	0.52%	51
2017 Q4	$423K	Buy	+4,981	New	+$417K	0.33%	90

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Claraphi Advisory Network's XBI Position: Q2 2020 in Review

Claraphi Advisory Network sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2020, closing a stake of 300 shares — an estimated $23K sold.

Claraphi Advisory Network first reported a position in XBI in Q4 2017 and held it in 7 quarters. The position peaked at $735K in Q1 2018. 525 funds tracked by Wall St. Rank hold XBI as of Q2 2020.

Claraphi Advisory Network reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2020 after selling out during the quarter.
Claraphi Advisory Network sold 300 State Street SPDR S&P Biotech ETF shares in Q2 2020, an estimated $23K.
Claraphi Advisory Network first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and held it in 7 quarters.
Claraphi Advisory Network's State Street SPDR S&P Biotech ETF position peaked at $735K in Q1 2018.
525 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2020.

Based on Claraphi Advisory Network's 13F filing for Q2 2020, filed 14 Aug 2020.